Beauty Health Company (The) - Class A
Current Price
$0.68
+3.26%Beauty Health Company (The) - Class A (SKIN) Stock Analysis
SKIN Financial Charts
FCF vs CAPEX
Cash vs Debt
Net Debt: 146M
Revenue
167M
FY19
119M
FY20
260M
FY21
366M
FY22
398M
FY23
334M
FY24
301M
FY25
Net Income
—
FY19
—
FY20
—
FY21
44M
FY22
—
FY23
—
FY24
—
FY25
SKIN 52-Week Range
Currently near its 52-week low — in the bottom 5% of its range.
Beauty Health Company (The) - Class A (SKIN) Financial Summary
Beauty Health Company (The) - Class A (SKIN) is a Consumer Defensive company in the Household & Personal Products industry, listed on NASDAQ. The stock currently trades at $0.68 with a market capitalization of $84.65M.
Key valuation metrics include a P/E ratio of -13.98, price-to-book ratio of 1.39, and EPS of $-0.16. The company reports a profit margin of -2.0% and return on equity of -9.9%.
SKIN Key Financial Metrics
| Metric | Value |
|---|---|
| Market Cap | $84.65M |
| P/E Ratio | -13.98 |
| EPS | $-0.16 |
| P/B Ratio | 1.39 |
| P/S Ratio | 0.29 |
| EV/EBITDA | 5.60 |
| Profit Margin | -2.0% |
| Return on Equity | -9.9% |
| Debt/Equity | 6.20 |
SKIN Revenue & Earnings History
| Year | Revenue | Net Income |
|---|---|---|
| FY19 | $166.62M | $-1.64M |
| FY20 | $119.09M | $-29.18M |
| FY21 | $260.09M | $-378.76M |
| FY22 | $365.88M | $44.22M |
| FY23 | $397.99M | $-100.12M |
| FY24 | $334.29M | $-29.10M |
| FY25 | $300.79M | $-9.52M |
SKIN Quality Indicators
Beauty Health Company (The) - Class A maintains a profit margin of -2.0% and an operating margin of -6.9%. Return on equity stands at -9.9%. The current ratio is 1.66. Debt-to-equity ratio is 6.20.
SKIN Free Cash Flow
Beauty Health Company (The) - Class A generated $32.32M in trailing twelve-month free cash flow, representing an FCF yield of 38.18%. This strong FCF yield suggests the company generates substantial cash relative to its market value.
SKIN Shares Outstanding
Beauty Health Company (The) - Class A has 0.12 billion shares outstanding at a share price of $0.68, giving it a market capitalization of $84.65M.